Bio Impact Capital LLC Context Therapeutics Inc. Put Options Transaction History
Bio Impact Capital LLC
- $540 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CNTX
# of Institutions
47Shares Held
71.6MCall Options Held
0Put Options Held
0-
Avidity Partners Management LP Dallas, TX7.48MShares$6.51 Million1.03% of portfolio
-
Nextech Invest Ag7.42MShares$6.45 Million1.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$6.45 Million0.16% of portfolio
-
Nextech Invest, Ltd. Zurich, V87.42MShares$6.45 Million1.06% of portfolio
-
Blue Owl Capital Holdings LP New York, NY7.37MShares$6.41 Million2.32% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $13.9M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...